References
- Allen R. M., Flemenbaum A. The effect of amantadine HCL on haloperidol‐induced striatal dopamene neuron hypersensitivity. Biological Psychiatry 1979; 14: 541–542
- Allen R. M. Role of amantadine in the management of neuroleptic‐induced extrapyramidal syndromes: Overview and Pharmacology. Clinical Neuropharmacology 1983; 6: 564–573
- Andrews J. M., Terry R., Spataro J. Striatonigral degeneration. Archives of Neurology 1970; 23: 319–329
- Borison R. L. Amantadine in the management of extrapyramical side effects. Clinical Neuropharmacology 1983; 6: 557–563, (suppl.)
- DiMascio A., Bernardo D. L., Greenblatt D. J., Marder J. E. A controlled trial of amantadine in drug‐induced extrapyramidal disorders. Archives of General Psychiatry 1976; 33: 599–602
- Fletcher E. A., Redfern P. H. The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates. Journal of pharmacy pharmacology 1970; 22: 957–959
- Klawans H. L. The pharmacology of extrapyramidal movement disorders. Karger, Basel 1973
- Klawans H. L., Lupton M. D., Simon L. Calcification of the basal ganglia as a cause of levo‐dopa‐resistant parkinsonism. Neurology 1976; 26: 221–225
- Markham C. H., Treciokas L. J., Diamond S. Parkinson's disease and L‐dopa. Western Journal of Medicine 1974; 121: 188–206
- Stone T. W., Bailey E. V. Responses of central neurones to amantadine: comparison with dopamine and amphetamine. Brain Research 1975; 85: 126
- Stromberg U., Svensson T. H., Waldeck B. On the mode of action of amantadine. Journal of Pharmacy Pharmacology 1970; 22: 959–962
- Sweet R. D., McDowell F. H. Five years treatment of Parkinson's disease with L‐dopa. Annals of Internal Medicine 1975; 83: 456–463
- Terzano M. G., Montanari E., Calzetti S., et al. The effect of amantadine on arousal and EEG patterns in Creutzfeld‐Jakob disease. Archives of Neurology 1983; 40: 555–559
- Vaatstar W. J., Eigeman L. Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine. European Journal of Pharmacology 1974; 25: 185–190
- Vardi J., Streifer M. On the synchronizing effect of amantadine‐1‐hydrochloride (Symmetrel) on pathological EEG activity. Journal of Neural Transactions 1975; 37: 73–80
- Weiner W. J., Kramer J., Nausidea P. A., Klawans H. L. Paradoxical response to dopaminergic agents in parkinsonism. Archives of Neurology 1978; 35: 453–455